Dong-A ST (Dong-A ST) announced on the 2nd that its first-quarter performance this year recorded sales of 140.062 billion KRW and an operating profit of 735 million KRW. Compared to the same period last year, sales increased by 3.7%, but operating profit decreased by 89.0%.


Exterior view of Dong-A ST headquarters building <br>[Photo by Dong-A ST]

Exterior view of Dong-A ST headquarters building
[Photo by Dong-A ST]

View original image

The company explained, "Sales increased due to growth in the ethical drugs (ETC) and overseas business sectors," adding, "Operating profit decreased due to increased research and development (R&D) expenses."



In the ETC sector, although sales of some prescription drug items declined, sales increased by 0.6% year-on-year to 101.6 billion KRW as the growth hormone product Grotrophin grew. The overseas business sector also grew by 16.6% year-on-year due to increased sales of Canbakkas in the Cambodia region.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing